University of South Florida

Rutgers, The State University of New Jersey

Spraingo, LLC

James William Leahy

Yu Chen

Xingmin Sun

Xiujun Zhang

Michael Sacco

Elena Bray

Bill J Baker

Dennis Edward Kyle

Stephen Bryant Liggett

Donghwa Kim

Sofia Kokkaliari

Brian Vesely

Benjamin Joe Eduful

Ankush Kanwar

Steven An

Zachary Paul Shultz

Linda Corrinne Barbeto

Grant Alexander Lawrence

Wayne Caleb Williams

Disclosed herein are compounds useful for treating obstructive lung diseases. The compounds are TAS2Rs agonists and may further be used to treat disorders and conditions implicated by TAS2R. In some instances the disclosed compounds can be used to treat asthma.

Bronchodilators for treating obstructive lung disease

Disclosed herein are compounds that can prevent and treatby inhibiting sporulation. Also disclosed herein are compositions and formulations comprising the compound disclosed herein. Methods of preventing and treatingcomprising administering the compounds described herein are also disclosed.

Small molecule inhibitors targetingsporulation

The present disclosure is directed to methods for the treatment of inflammation or pain, particularly methods using compositions containing a compound of formula (I).

Methods for the treatment of inflammation

Provided are synthesis processes and intermediates for preparing cannabinoids and analogs.

Synthesis of cannabinoids

The present disclosure provides compositions including a compound (e.g., compounds A-D), pharmaceutical compositions including the compound, methods of treatment of a condition (e.g., an infection) or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.

Antimicrobial compositions, methods of use, and methods of treatment of infections

Growing community of inventors

Lutz, FL, United States of America

James William Leahy